Valiant Laboratories Limited (NSE:VALIANTLAB)
68.00
+0.97 (1.45%)
Jun 12, 2026, 3:29 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 3.69 billion as of June 12, 2026. Its market cap has decreased by -16.32% in one year.
Market Cap
3.69B
Enterprise Value
3.82B
Revenue
2.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
68.00
Market Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 3.69B, a decrease of -50.07%. That is a compound annual growth rate of -22.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 3.69B | -2.86% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Windlas Biotech | 17.40B |
| Jagsonpal Pharmaceuticals | 14.19B |
| Ind-Swift Laboratories | 14.14B |
| Sigachi Industries | 7.89B |
| Bafna Pharmaceuticals | 3.91B |
| Nectar Lifesciences | 2.25B |
| Brooks Laboratories | 1.96B |
| Alpa Laboratories | 1.47B |